Skip to main content
CHA Vaccine Research Institute logo

CHA Vaccine Research Institute — Investor Relations & Filings

Ticker · 261780 ISIN · KR7261780001 KO Manufacturing
Filings indexed 139 across all filing types
Latest filing 2026-05-04 Regulatory Filings
Country KR South Korea
Listing KO 261780

About CHA Vaccine Research Institute

http://en.chavaccine.com/

CHA Vaccine Research Institute is a research-oriented biotechnology company focused on developing vaccines and immunotherapeutics for the prevention and treatment of infectious diseases. The company's core strategy involves leveraging proprietary adjuvant platforms, such as L-pampo and L-pampo, which are based on Toll-like receptor (TLR) ligands, to enhance vaccine efficacy. Its development pipeline includes a third-generation prophylactic vaccine and a therapeutic vaccine for Hepatitis B (HBV), a recombinant vaccine for herpes zoster (shingles), and an improved influenza vaccine. In addition to its vaccine portfolio, the institute is developing immunotherapeutic proteins like recombinant Mannose-Binding Lectin (MBL) for broad-spectrum pathogen suppression.

Recent filings

Filing Released Lang Actions
주권관련사채권의취득결정
Regulatory Filings
2026-05-04 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Regulatory Filings
2026-05-04 Korean
임시주주총회결과
Regulatory Filings
2026-04-30 Korean
상호변경안내
Regulatory Filings
2026-04-30 Korean
최대주주변경
Regulatory Filings
2026-04-30 Korean
최대주주변경을수반하는주식담보제공계약체결
Regulatory Filings
2026-04-30 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.